Jefferies Reiterates Buy Rating on Kenvue Inc (KVUE)

Jefferies analyst Keith Devas reiterated a Buy rating and $27.00 price target on Kenvue Inc (NYSE: KVUE).

The analyst commented: "With Starboard's position, the question becomes how long will a skin care inflection take. We think a rebound occurs in '26; large brand turnarounds take time. Better Neutrogena social media traction and hiring trends across key functions are early/encouraging signs. Starboard's involvement raises the stakes. Pressure is good. It may accelerate Kenvue's growth transformation."

For an analyst ratings summary and ratings history on Kenvue Inc click here. For more ratings news on Kenvue Inc click here.

Shares of Kenvue Inc closed at $22.76 yesterday.

You May Also Be Interested In

• Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
• Quantinuum raises $1.68 billion in US IPO at $60 per share - Reuters
• Dover Corp. (DOV) PT Raised to $230 at Morgan Stanley